Perrigo Company plc Assets, Fair Value Disclosure
Perrigo Company plc (PRGO) had Assets, Fair Value Disclosure of $37.80 million as of 2015-09-26, per its 10-Q filed 2015-11-02.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2015-11-02
- 2015-09-26: Assets, Fair Value Disclosure $37.80M.
- 2015-06-27: Assets, Fair Value Disclosure $42.40M.
- 2015-03-28: Assets, Fair Value Disclosure $43.30M.
- 2014-12-27: Assets, Fair Value Disclosure $39.60M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2015-09-26 | $37.80M 10-Q · filed 2015-11-02 |
| 2015-06-27 | $42.40M 10-Q · filed 2015-11-02 |
| 2015-03-28 | $43.30M 10-Q · filed 2015-04-29 |
| 2014-12-27 | $39.60M 10-Q · filed 2015-02-05 |
| 2014-09-27 | $40.80M 8-K · filed 2014-11-20 |
| 2014-06-28 | $43.10M 10-K · filed 2015-08-13 |
| 2013-06-29 | $24.10M 10-K · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |